Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 2/2018

01-02-2018 | Letter to the Editors

No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas

Authors: Fabian Trillsch, Peter Eichhorn, Leticia Oliveira-Ferrer, Tania Kuempfel, Alexander Burges, Sven Mahner, Joachim Havla

Published in: Journal of Neurology | Issue 2/2018

Login to get access

Excerpt

Dear Sirs, …
Appendix
Available only for authorised users
Literature
1.
Prat J, FIGO Committee on Gynecologic Oncology (2014) Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 124:1–5CrossRefPubMed
2.
Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157–165CrossRefPubMedPubMedCentral
3.
Gong S, Zhou M, Shi G, Guo J, Chen N, Yang R, He L, Zhou D (2017) Absence of NMDA receptor antibodies in patients with ovarian teratoma without encephalitis. Neurol Neuroimmunol Neuroinflamm 4:e344CrossRefPubMedPubMedCentral
4.
Mangler M, Trebesch de Perez I, Teegen B, Stocker W, Pruss H, Meisel A, Schneider A, Vasiljeva J, Speiser D (2013) Seroprevalence of anti-N-methyl-d-aspartate receptor antibodies in women with ovarian teratoma. J Neurol 260:2831–2835CrossRefPubMed
5.
Chan JK, Brady MF, Penson RT, Huang H, Birrer MJ, Walker JL, DiSilvestro PA, Rubin SC, Martin LP, Davidson SA, Huh WK, O’Malley DM, Boente MP, Michael H, Monk BJ (2016) Weekly vs. every-3-week paclitaxel and carboplatin for ovarian cancer. N Engl J Med 374:738–748CrossRefPubMedPubMedCentral
Metadata
Title
No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas
Authors
Fabian Trillsch
Peter Eichhorn
Leticia Oliveira-Ferrer
Tania Kuempfel
Alexander Burges
Sven Mahner
Joachim Havla
Publication date
01-02-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 2/2018
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8717-3

Other articles of this Issue 2/2018

Journal of Neurology 2/2018 Go to the issue

Original Communication

Stroke-associated infection independently predicts 3-month poor functional outcome and mortality

Original Communication

Evaluation of the yield of 24-h close observation in patients with mild traumatic brain injury on anticoagulation therapy: a retrospective multicenter study and meta-analysis

Original Communication

Ocular ultrasound for monitoring pseudotumor cerebri syndrome

Letter to the Editors

Voluntary control of a plegic limb during yawning

Original Communication

Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis

Original Communication

Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis